Prestige BioPharma Revenue

In the fiscal year ending June 30, 2024, Prestige BioPharma had annual revenue of 689.08M KRW with 325.77% growth. Prestige BioPharma had revenue of -137.09M in the quarter ending June 30, 2024, a decrease of -184.71%.

Revenue

689.08M

Revenue Growth

+325.77%

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

n/a

Market Cap

170.19B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	689.08M	527.23M	325.77%
Jun 30, 2023	161.84M	-	-
Jun 30, 2022	-	-	-
Jun 30, 2021	-	-	-
Jun 30, 2020	-	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition